Merck & Co announced that its HPV vaccine has received approval from China's medical products administration for use in males aged 9-26 years. This marks a significant development in extending ...

China’s drug regulator approved Merck & Co.’s blockbuster HPV vaccine for use by men, opening a new untapped market for the ...

U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's ...

Truist Financial analyst Srikripa Devarakonda downgraded Merck & Company (MRK – Research Report) to a Hold yesterday and set a price target ...

This was the stock's second consecutive day of gains.

Richard Rossi, who started at the bottom of the legal department in 2001 and rose to general counsel in 2018, now is taking another step up.

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...

Selected preclinical small molecule candidates will now be tested through the Quris-AI platform prior to initiating clinical trials. This follows a successful two-year validation study with Merck KGaA ...

This summary highlights pressing health-related issues worldwide. Topics include President Trump considering protective ...

Gene Mack Has Served As CFO Since April 2024 And Interim CEO Since June 2024Gianluca Fuggetta Will Assume The Role Of Senior Vice President, ...

Vertex is paying Orna $65 million upfront, in part via convertible note, according to a Jan. 7 release. Orna—which acquired ...